¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"volume averaging effect"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • volume gradient echo technique
    ¿ëÀû±â¿ï±â¿¡ÄÚ±â¹ý
  • volume index
    ºÎÇÇÁö¼ö
  • volume of distribution
    ºÐÆ÷¿ëÀû
  • volume overload
    ¿ëÀû°úºÎÇÏ
  • volume pulse
    ¿ëÀû¸Æ¹Ú
  • volume receptor
    ¿ëÀû¼ö¿ë±â
  • volume-cycled ventilator
    ¿ëÀûÁÖ±âÇüȯ±â±â
  • antagonistic effect
    ´ëÇ×È¿°ú
  • anticoagulant effect
    Ç×ÀÀ°íÈ¿°ú
  • antioxidant effect
    Ç×»êÈ­È¿°ú
  • antitussive effect
    Ç×±âħȿ°ú, ÁøÇØÈ¿°ú
  • additive effect
    ºÎ°¡È¿°ú
  • adverse effect
    À¯ÇØÈ¿°ú
  • beam hardening effect
    ºö°æÈ­È¿°ú
  • back-pressure effect
    ÈĹæ¾Ð·ÂÈ¿°ú
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • residual volume
    Àܱⷮ, ³²Àº°ø±â·®
  • stroke volume
    ÀÏȸ¹ÚÃâ·®
  • tidal volume
    ÀÏȸȣÈí·®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • minute volume
    ºÐ´çÈ£Èí·®, ºÐ´ç¹ÚÃâ·®
  • obligatory urine volume
    Ãּұ⺻´¢·®
  • packed cell volume
    ÃæÀü¼¼Æ÷¿ëÀû, ³óÃ༼Æ÷¿ëÀû
  • phonatory air volume
    ¹ß¼º½Ã°ø±â·®
  • planning target volume
    °èȹǥÀûºÎÇÇ
  • pressure volume relation
    ¾Ð·Â¿ëÀû°ü°è
  • volume pulse
    ¿ëÀû¸Æ¹Ú
  • relative osteoid volume
    »ó´ëÀ¯°ñ·®
  • residual volume
    Àܱⷮ, ³²Àº°ø±â·®
  • volume receptor
    ¿ëÀû¼ö¿ëü
  • stroke volume
    ÀÏȸ¹ÚÃâ·®
  • volume speed
    ºÎÇÇÁö¼Óµµ, ¿ëÀûÁö¼Óµµ
  • volume magnetic susceptibility
    ¿ëÀûÀÚ±âÈ­À²
  • throughput volume
    ¿Ï·á·®
  • tidal volume
    ÀÏȸȣÈí·®
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Bohr effect
    º¸¾Æ È¿°ú(üùÍý)
  • CPE=£¾cytopathogenic effect
    ¼¼Æ÷º´º¯È¿°ú.
  • CPE=£¾cytopathogenic effect
    ¼¼Æ÷º´º¯È¿°ú.
  • Cytopath(ogen)ic effect, CPE
    ¼¼Æ÷º´º¯È¿°ú
  • Donnan effect
    µ·³­È¿°ú
  • Doppler effect
    µµÇ÷¯ È¿°ú
  • Fahraeus-Lindqvist effect
    ÆÄ·¹¿ì½º-¸°Äûºñ½ºÆ® È¿°ú(üùÍý)
  • Fenn effect
    Ææ È¿°ú(üùÍý)
  • Gibbs effect
    ±é½º È¿°ú
  • HIV effect
    HIV È¿°ú<ÀÛ¿ë>
  • Haldane effect
    ÇÒµ§È¿°ú
  • Purkinje effect
    Ǫ¸£Å°´Ï¿¡È¿°ú
  • RF antennae effect
    °íÁÖÆÄ ¾ÈÅ׳ª È¿°ú
  • Stiles-Crawford effect
    ½ºÅ¸ÀϽº-Å©·ÎÆ÷µåÈ¿°ú
  • T1 shortening effect
    T1 ´ÜÃà È¿°ú
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • effective blood volume
    À¯È¿Ç÷¾×·®.
  • effective circulating volume
    À¯È¿¼øÈ¯¿ëÀû(êóüùâàü»é»îÝ)
  • end-diastolic volume
    È®Àå±â¸»¿ëÀû(¡­éÄîÝ)
  • end-systolic volume
    ¼öÃà±â¸»¿ëÀû(¡­éÄîÝ)
  • enddiastolic volume
    È®À帻±â¿ëÀû.
  • erythrocyte volume measurement
    ÀûÇ÷±¸¿ëÀûÃøÁ¤
  • expiratory reserve volume =ERV
    È£½Ä¼º ¿¹ºñ¿ëÀû(û¼ãÓàõçãÝáé»îÝ). ¸¶ Ãë È£±â¿¹ºñ·®, ¿¹ºñÈ£±â
  • expiratory reserve volume =ERV
    È£±â¿¹ºñ·®, ¿¹ºñÈ£±â·®, È£½Ä¼º ¿¹ºñ¿ëÀû
  • extracellular liquid volume
    ¼¼Æ÷¿Ü¾×·®(¡­äûåÖ).
  • flow volume curve
    À¯·®¿ë·®°î¼±(êüÕáé»ÕáÍØàÊ).
  • flow-volume curve
  • forced expiratory volume
    °­Á¦È£±â(ÆóȰ)·®, ³ë·ÂÈ£±âÆóȰ·®
  • forced expiratory volume = FEV
    °­Á¦È£±â(ÆóȰ)·®, ³ë·ÂÈ£±âÆóȰ·®
  • forced expiratory volume =FEV
    °­Á¦È£±â(ÆóȰ(øËüÀ))·®, ³ë·ÂÈ£±âÆóȰ·®(Ò½æ³ û¼Ñ¨øËüÀåÖ).
  • forced expiratory volume =FEV
    °­Á¦È£±â(ÆóȰ)·®, ³ë·ÂÈ£±âÆóȰ·®
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • electrophoretic effect
    Àü±â¿µµ¿ È¿°ú(ï³Ñ¨ç¶ÔÑüùÍý)
  • electroviscous effect
    Àü±âÁ¡¼º È¿°ú(ï³Ñ¨ïÄàõüùÍý)
  • enhancement effect
    Áõ°­ È¿°ú (ñòË­üùÍý)
  • extrinsic Cotton effect
    ¿ÜÀμº(èâì×àõ) ÄÚÆ° È¿°ú(üùÍý)
  • Faraday effect
    ÆÐ·¯µ¥ÀÌ È¿°ú(üùÍý)
  • field effect
    ÀåÈ¿°ú(íÞüùÍý)
  • founder effect
    ½ÃÁ¶ È¿°ú(ã·ðÓüùÍý)
  • glucose effect
    ±Û·çÄÚ½º È¿°ú(üùÍý)
  • Haldane effect
    Ȧµ¥ÀÎ È¿°ú(üùÍý)
  • heterotropic effect
    ÀÌÁú È¿°ú(ì¶òõüùÍý)
  • homoptropic effect
    µ¿Áú È¿°ú(ÔÒòõüùÍý)
  • hydrophobic effect
    ¼Ò¼ö È¿°ú(áÂâ©áÂâ©)
  • hyperchromic effect
    Èí±¤Áõ°¡ È¿°ú (ýåÎÃñòÊ¥üùÍý)
  • hypochromic effect
    Èí±¤ °¨¼Ò È¿°ú(ýåÎÃÊõá´üùÍý)
  • induction effect
    À¯µµÈ¿°ú(ë¯ÓôüùÍý)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • fast scan effect
    °í¼Ó½ºÄµÈ¿°ú
  • Gibbs effect
    ±é½º È¿°ú
  • gradient echo effect
    °æ»ç¿¡ÄÚÈ¿°ú
  • gradient induced phase shift effect
    °æ»çÀ¯µµ À§»óº¯À§È¿°ú
  • halo effect
    ´Þ¹«¸®È¿°ú
  • immediate effect
    Áﰢȿ°ú, Áï½ÃÈ¿°ú
  • in-flow effect
    À¯ÀÔ È¿°ú
  • iron effect
    öȿ°ú
  • mach effect
    ¸¶ÇÏÇö»ó
  • magnetization transfer effect
    ÀÚÈ­Àü´ÞÈ¿°ú
  • main effect
    ÁÖÀÛ¿ë
  • mass effect
    Á¾±«È¿°ú
  • misregistration effect
    ¿Àµî·ÏÈ¿°ú
  • oblique angle effect
    »ç°¢È¿°ú
  • paramagnetic susceptibility effect
    »óÀÚ¼ºÀÚ±âÈ­È¿°ú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
OV oculovestibular; office visit; osteoid volume; outflow volume; ovalbumin; ovary; overventilation; ov...
PBV predicted blood volume; pulmonary blood volume
PVR peripheral vascular resistance; perspective volume rendering; poliovirus receptor; postvoiding resid...
RV random variable; rat virus; Rauscher virus; rectovaginal; reinforcement value; renal vein; residual ...
TV talipes varus; television; tetrazolium violet; thoracic vertebra; tickborne virus; tidal volume; tot...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
LOEL Lowest Observed Effect Level
LOEC Lowest observed effect concentrations
ME McCollough Effect
NOAEL No Observable Adverse Effect Level
NOEL No Observable Effect Level
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • volume elasticity
    ¿ëÀû ź¼º
  • volume expander
    Ç÷·® Áõ·®Á¦
  • volume overload
    Ç÷·® °úºÎÇÏ
  • volume receptor
    ¿ëÀû ¼ö¿ë±â
  • volume sensitive respirator
    Á¦·® ÀΰøÈ£Èí±â, ¿ë·® Á¦ÇÑ ÀΰøÈ£Èí±â
  • weight/volume percent
    üÁß/¿ëÀû ·ü
  • additive effect
    ÷°¡ È¿°ú, »óÇÕÈ¿°ú
    ¼­·Î ´Ù¸¥ µÎ ¾à¹°À» ¾î´À Á¤µµ±îÁöÀÇ ¿ë·® ¹üÀ§ ³»¿¡¼­ µ¿½Ã¿¡ Åõ¿©ÇÒ °æ¿ì ±× È¿°ú´Â µÎ ¾à¹°À» °¢°¢ ´Üµ¶À¸·Î Åõ¿©ÇÏ¿´À» ¶§ ³ªÅ¸³ª´Â ÀÛ¿ëÀÇ »ê¼úÀûÀÎ ÇÕ¸¸À¸·Î ³ªÅ¸³ª´Â ÀÛ¿ë.
  • adrenal suppressive effect
    ºÎ½Å ¾ïÁ¦ È¿°ú
  • air gap effect
    °ø±â °£°Ý È¿°ú
  • allogenic effect
    µ¿Á¾ ¼¼Æ÷ ¹ÝÀÀ È¿°ú
    µ¿Á¾ÀÇ ¸²ÇÁ°í¸¦ Åõ¿©ÇÔÀ¸·Î½á ºñƯÀÌÀûÀ¸·Î ¸é¿ª¹ÝÀÀÀÌ Áõ°¡µÇ±âµµ ÇÏ°í ¾ïÁ¦µÇ±âµµ ÇÏ´Â Çö»ó. Áõ°¡µÈ °æ¿ì¸¦ Á¤ÀÇ allogenic È¿°ú, ¾ïÁ¦µÈ °æ¿ì¸¦ ºÎÀÇ allogenic È¿°ú¶ó°í ÇÑ´Ù.
  • anticurare effect
    Ç×Å¥¶ó·¹ ÀÛ¿ë
  • antitussive effect
    ÁøÇØ È¿°ú
  • autonomic effect
    ÀÚÀ² ½Å°æ¼º È¿°ú, ÀÚÀ² ½Å°æ È¿°ú
  • balloning effect
    ÆØÃ¢ È¿°ú
  • Bernouilli effect
    º£¸£´©ÀÌ È¿°ú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
interstitial lung disease with increased volume <radiology> Cystic fibrosis (CF), eosinophilic granuloma (EG), lymphangioleiomyomatosis (LAM)
(12 Dec 1998)
tidal volume The volume of air inspired or expired during each normal, quiet respiratory cycle. Common abbreviations are tv or v with subscript t.
(12 Dec 1998)
elution volume <chemistry> The amount of eluant which has passed through the column in column chromatography before a particular peak in an elution profile appears, or before a specific substance of interest comes out with the eluant, separated out of the original mixed substance.
(09 Oct 1997)
end-diastolic volume The amount of blood in the ventricle immediately before a cardiac contraction begins; a measurement of cardiac filling between beats, related to diastolic function.
(05 Mar 2000)
end-systolic volume The amount of blood in the ventricle at the end of the cardiac ejection period and immediately preceding the beginning of ventricular relaxation; a measurement of the adequacy of cardiac emptying, related to systolic function.
(05 Mar 2000)
erythrocyte volume Volume of circulating erythrocytes. It is usually measured by radioisotope dilution technique.
(12 Dec 1998)
expiratory reserve volume The extra volume of air that can be expired with maximum effort beyond the level reached at the end of a normal, quiet expiration. Common abbreviation is erv.
(12 Dec 1998)
extracellular fluid volume The fraction of body wate rnot in cells; about 25% of body weight. It consists of plasma water (4.5% of body weight), water between cells (interstitial water-lymph, 11.5% of body weight), water in dense bone and connective tissue (7.5% of body weight) and water secretions.See transcellular water, about 1.5% of body weight..
(05 Mar 2000)
flow-volume curve The graph produced by plotting the instantaneous flow of respiratory gas against the simultaneous lung volume, usually during maximal forced expiration.
(05 Mar 2000)
foliage volume <botany> The space, expressed in cubic metres, occupied by a tree.
(12 Nov 1997)
forced expiratory volume Measure of the maximum amount of air during a forced vital capacity determination that can be expelled in a given number of seconds. It is usually given as fev followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity.
(12 Dec 1998)
left ventricular volume overload <radiology> VSD, patent ductus arteriosus, mitral incompetence, aortic incompetence
(12 Dec 1998)
lung volume measurements Measurement of the amount of air that the lungs may contain at various points in the respiratory cycle.
(12 Dec 1998)
abscopal effect A reaction produced following irradiation but occurring outside the zone of actual radiation absorption.
(05 Mar 2000)
additive effect <biochemistry, chemistry> An additive effect is the overall biological effect two chemicals acting together and which is the simple sum of the effects of the chemicals acting independently.
Compare: antagonism.
(15 Jan 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • stage effect
    ¹«´ë È¿°ú
  • tunnel effect
    ÅͳΠȿ°ú !
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á